Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors

Bioorg Med Chem. 2009 Aug 1;17(15):5369-73. doi: 10.1016/j.bmc.2009.06.056. Epub 2009 Jun 27.

Abstract

A new group of 1, 3-benthiazinan-4-ones, possessing a methyl sulfonyl pharmacophore, were synthesized and their biological activities were evaluated for cyclooxygenase-2 (COX-2) inhibitory activity. In vitro COX-1/COX-2 inhibition studies identified 3-(p-fluoropheny)-2-(4-methylsulfonylphenyl)-1,3-benzthiazinan-4-one (7b) as a potent (IC(50)=0.05 microM) and selective (selectivity index=259) COX-2 inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catalytic Domain
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase Inhibitors / chemical synthesis
  • Cyclooxygenase Inhibitors / chemistry*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Drug Design
  • Models, Molecular
  • Molecular Structure
  • Murinae
  • Protein Binding
  • Structure-Activity Relationship
  • Thiazines / chemical synthesis
  • Thiazines / chemistry*
  • Thiazines / pharmacology*

Substances

  • 1,3-benzthiazinan-4-one
  • Cyclooxygenase Inhibitors
  • Thiazines
  • Cyclooxygenase 2